BUSINESS: Harrow Health, Inc. owns a portfolio of healthcare businesses, including the nation’s leading ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds large equity ...
Harrow missed estimated earnings by -62.22%, reporting an EPS of $0.17 versus an estimate of $0.45. Revenue was up $22.26 million from the same period last year. During the previous quarter, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results